脂質制御の世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D05905)
◆英語タイトル:Global Lipid Regulators Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D05905
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年11月30日(※2024年版があります。お問い合わせください。)
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、脂質制御の世界市場について調査・分析し、種類別には、スタチン、非スタチンに、用途別には、オンライン、小売に区分してまとめました。調査対象企業は、Abbott Laboratories、Andrx Corporation、Astrazeneca、Atellas Pharma、Bristol-Myers Squibb、Pfizer、Novartis、Merck、Teva Pharmaceuticals、Bentley Pharmaceuticals等です。

・レポートの概要
・グローバル成長トレンド
・脂質制御の世界市場規模
・脂質制御の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別脂質制御の価格動向
・脂質制御の種類別市場規模(スタチン、非スタチン)
・脂質制御の用途別市場規模(オンライン、小売)
・脂質制御の北米市場(アメリカ、カナダ、メキシコ)
・脂質制御のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・脂質制御のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・脂質制御の中南米市場(ブラジル等)
・脂質制御の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Abbott Laboratories、Andrx Corporation、Astrazeneca、Atellas Pharma、Bristol-Myers Squibb、Pfizer、Novartis、Merck、Teva Pharmaceuticals、Bentley Pharmaceuticals)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・脂質制御の市場規模予測
・脂質制御の種類別市場予測2018-2025(スタチン、非スタチン)
・脂質制御の用途別市場予測2018-2025(オンライン、小売)
・脂質制御の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・脂質制御のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・脂質制御のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・脂質制御の中南米市場予測2018-2025(ブラジル等)
・脂質制御の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Lipid regulators or lipid-regulating drugs are used to treat dyslipidemias, cardiovascular problems, osteoporosis and post-menopause complications. This is why these lipid regulators come under class of most prescribed medications. A study reveals that more than 255.4 million prescriptions are being filled each year for these statins. Lipid regulators including a full range of statin and non-statin products energize the statin market.In 2018, the global Lipid Regulators market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Lipid Regulators.

This study researches the market size of Lipid Regulators, presents the global Lipid Regulators sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Lipid Regulators in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Lipid Regulators for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Abbott Laboratories
Andrx Corporation
Astrazeneca
Atellas Pharma
Bristol-Myers Squibb
Pfizer
Novartis
Merck
Teva Pharmaceuticals
Bentley Pharmaceuticals

Market Segment by Product Type
Statins
Non-statins

Market Segment by Application
Online
Pharmancy store
Retail

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Lipid Regulators status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Lipid Regulators manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Lipid Regulators are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Lipid Regulators Market Size Growth Rate by Type
1.3.2 Statins
1.3.3 Non-statins
1.4 Market Segment by Application
1.4.1 Global Lipid Regulators Market Share by Application (2018-2025)
1.4.2 Online
1.4.3 Pharmancy store
1.4.4 Retail
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Lipid Regulators Market Size
2.1.1 Global Lipid Regulators Revenue 2013-2025
2.1.2 Global Lipid Regulators Sales 2013-2025
2.2 Lipid Regulators Growth Rate by Regions
2.2.1 Global Lipid Regulators Sales by Regions 2013-2018
2.2.2 Global Lipid Regulators Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Lipid Regulators Sales by Manufacturers
3.1.1 Lipid Regulators Sales by Manufacturers 2013-2018
3.1.2 Lipid Regulators Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Lipid Regulators Revenue by Manufacturers (2013-2018)
3.2.2 Lipid Regulators Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Lipid Regulators Market Concentration Ratio (CR5 and HHI)
3.3 Lipid Regulators Price by Manufacturers
3.4 Key Manufacturers Lipid Regulators Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Lipid Regulators Market
3.6 Key Manufacturers Lipid Regulators Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Statins Sales and Revenue (2013-2018)
4.1.2 Non-statins Sales and Revenue (2013-2018)
4.2 Global Lipid Regulators Sales Market Share by Type
4.3 Global Lipid Regulators Revenue Market Share by Type
4.4 Lipid Regulators Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Lipid Regulators Sales by Application

6 North America
6.1 North America Lipid Regulators Breakdown Data by Company
6.2 North America Lipid Regulators Breakdown Data by Type
6.3 North America Lipid Regulators Breakdown Data by Application
6.4 North America Lipid Regulators Breakdown Data by Countries
6.4.1 North America Lipid Regulators Sales by Countries
6.4.2 North America Lipid Regulators Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Lipid Regulators Breakdown Data by Company
7.2 Europe Lipid Regulators Breakdown Data by Type
7.3 Europe Lipid Regulators Breakdown Data by Application
7.4 Europe Lipid Regulators Breakdown Data by Countries
7.4.1 Europe Lipid Regulators Sales by Countries
7.4.2 Europe Lipid Regulators Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Lipid Regulators Breakdown Data by Company
8.2 Asia Pacific Lipid Regulators Breakdown Data by Type
8.3 Asia Pacific Lipid Regulators Breakdown Data by Application
8.4 Asia Pacific Lipid Regulators Breakdown Data by Countries
8.4.1 Asia Pacific Lipid Regulators Sales by Countries
8.4.2 Asia Pacific Lipid Regulators Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Lipid Regulators Breakdown Data by Company
9.2 Central & South America Lipid Regulators Breakdown Data by Type
9.3 Central & South America Lipid Regulators Breakdown Data by Application
9.4 Central & South America Lipid Regulators Breakdown Data by Countries
9.4.1 Central & South America Lipid Regulators Sales by Countries
9.4.2 Central & South America Lipid Regulators Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Lipid Regulators Breakdown Data by Type
10.2 Middle East and Africa Lipid Regulators Breakdown Data by Application
10.3 Middle East and Africa Lipid Regulators Breakdown Data by Countries
10.3.1 Middle East and Africa Lipid Regulators Sales by Countries
10.3.2 Middle East and Africa Lipid Regulators Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Lipid Regulators
11.1.4 Lipid Regulators Product Introduction
11.1.5 Abbott Laboratories Recent Development
11.2 Andrx Corporation
11.2.1 Andrx Corporation Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Lipid Regulators
11.2.4 Lipid Regulators Product Introduction
11.2.5 Andrx Corporation Recent Development
11.3 Astrazeneca
11.3.1 Astrazeneca Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Lipid Regulators
11.3.4 Lipid Regulators Product Introduction
11.3.5 Astrazeneca Recent Development
11.4 Atellas Pharma
11.4.1 Atellas Pharma Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Lipid Regulators
11.4.4 Lipid Regulators Product Introduction
11.4.5 Atellas Pharma Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Lipid Regulators
11.5.4 Lipid Regulators Product Introduction
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Lipid Regulators
11.6.4 Lipid Regulators Product Introduction
11.6.5 Pfizer Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Lipid Regulators
11.7.4 Lipid Regulators Product Introduction
11.7.5 Novartis Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Lipid Regulators
11.8.4 Lipid Regulators Product Introduction
11.8.5 Merck Recent Development
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Lipid Regulators
11.9.4 Lipid Regulators Product Introduction
11.9.5 Teva Pharmaceuticals Recent Development
11.10 Bentley Pharmaceuticals
11.10.1 Bentley Pharmaceuticals Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Lipid Regulators
11.10.4 Lipid Regulators Product Introduction
11.10.5 Bentley Pharmaceuticals Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Lipid Regulators Sales Channels
12.2.2 Lipid Regulators Distributors
12.3 Lipid Regulators Customers

13 Market Forecast
13.1 Global Lipid Regulators Sales and Revenue Forecast 2018-2025
13.2 Global Lipid Regulators Sales Forecast by Type
13.3 Global Lipid Regulators Sales Forecast by Application
13.4 Lipid Regulators Forecast by Regions
13.4.1 Global Lipid Regulators Sales Forecast by Regions 2018-2025
13.4.2 Global Lipid Regulators Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Lipid Regulators Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Lipid Regulators Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Lipid Regulators Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Lipid Regulators Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Lipid Regulators Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Abbott Laboratories、Andrx Corporation、Astrazeneca、Atellas Pharma、Bristol-Myers Squibb、Pfizer、Novartis、Merck、Teva Pharmaceuticals、Bentley Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 脂質制御の世界市場動向・分析2018-2025(Global Lipid Regulators Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。